CRISPR
Risk Mitigation Strategies For Gene Therapy Developers
In recent weeks, a handful of scientific articles in peer-reviewed medical literature, as well as alarmist headlines in the popular press, have …
Genetic EngineeringSynthetic Bio continues slide, down 15%
Nano cap Synthetic Biologics (SYN -14.8%) is down on below-average volume. Shares have lost almost 65% of their value since announcing a 1:35 reverse …
BusinessCRISPR First Look At June 2018 Updates
<i>ISTOCK, BUBAONE</i><p>We obtained approval of Clinical Trial Applications (CTA) in multiple countries for both β-thalassemia and sickle cell disease (SCD) …
BusinessWhat will the Doctor order?
By Melissa Hogenboom<p>Our quest to understand how our genes work started in earnest in the mid-19th Century when a biologist and monk called Gregor Mendel came to a startling conclusion about the traits of plants. He crossed purple flowered pea plants with white ones, and found that all the resulting …
GeneticsOpinion: Using CRISPR for the ‘smaller wins,’ like making chemotherapy less toxic
Although the phrase “war on cancer” was first uttered in 1971, the breakthroughs in biomedical research that have emerged during this decade have …
GeneticsKidney CRISPR: How Close Are We?
CRISPR (clustered regularly interspaced short palindromic repeats) gene editing is making huge waves in biomedical research. In fact, the lay press …
Genetic EngineeringCRISPR Can Track Cellular History of a Mammalian Embryo
Researchers used the genome-editing technology to analyze the development of mouse tissues.
GeneticsCRISPR Method Dramatically Improves Gene Editing Delivery to Mosquitoes
The recent abundance of studies and ensuing data associated with the CRISPR genome editing system would lead some to believe that use of this …
GeneticsWachtel Award Honors Two Innovative Cancer Researchers
Neville Sanjana (left), Tom Misteli, Omer Yilmaz, Yevgeniya Nusinovich, and AAAS CEO Rush Holt at the Wachtel Awards ceremony at the National …
CancerCRISPR ‘barcodes’ map mammalian development in exquisite detail
NEWS<p>09 August 2018<p>Genome-editing technique enables researchers to trace lineage of cells in developing mice.<p>Search for this author in:<p>Pub …
GeneticsIs CRISPR Gene Editing Doomed, Even As Gene Therapy Enters the Clinic? | DNA Science Blog
Anyone watching the recent <i>60 Minutes</i> segment on CRISPR would conclude that the gene editing technology is on the brink of pouring forth a cascade of …
GeneticsWhy Gene Editing Is the Next Food Revolution
Environment<p>Crispr has the potential to boost yields, disease resistance, and taste, and even tackle allergens like gluten. It could radically change how we breed and grow crops—and scientists say they're working only with nature's tools.<p>Tucked into a suburban Long Island neighborhood, a 12-acre …
GeneticsThose CRISPR’d human embryos? We got it right, scientists insist
Shoukhrat Mitalipov of Oregon Health and Science University and his colleagues report that they re-tested the embryos — and got the same results.
GeneticsCRISPR/Cas9 players give up gains on (another) report of off-target effects
The research paper rollercoaster continues for CRISPR/Cas9 gene editors Editas Medicine (EDIT +3.1%), CRISPR Therapeutics (CRSP +2%) and Intellia …
BusinessScientists Take a Harder Look at Genetic Engineering of Human Embryos
The distant future of designer babies might not seem so distant after all. The last year has been full of news about genetic engineering—much of it …
GeneticsVisa, Zuora, CRISPR, Tractor Supply: 'Mad Money' Lightning Round
Here's what Jim Cramer had to say about some of the stocks during the <i>Mad Money Lightning Round</i>:<p>Visa (V) : "Visa and Mastercard (MA) have both been …
InvestingBREAKING: Flagship's Latest Venture Inari Raises $40m Series B to "Transform Plant Breeding"
Inari, the latest venture from venture development organization Flagship Pioneering, has raised $40 million in Series B funding.<p>The company describes …
Is Crispr Therapeutics Stock Grossly Overvalued?
Despite a wave of bad news for gene-editing companies employing the CRISPR/Cas 9 system as of late, shares of <b>Crispr Therapeutics</b> (NASDAQ: CRSP) have …
GeneticsGene-Editing Technique in Human Embryos Draws Skepticism
Critics challenge a study saying a disease-causing gene mutation was repaired in human embryos<p>Scientists are challenging a high-profile study that found a popular gene-editing tool could be used to repair a disease-causing mutation in human embryos.<p>Two papers published in the journal Nature on …
GeneticsOHSU's Mitalipov confirms earlier gene editing breakthrough after critics raise doubts - Portland Business Journal
By Elizabeth Hayes <br>– Staff Reporter, Portland Business Journal<p>Aug 8, 2018, 10:15am PDT<b><br>Updated</b> Aug 8, 2018, 10:51am PDT<p>Just weeks after an Oregon …
GeneticsPotato Company Simplot Licenses DowDuPont’s Gene Editing Tech
By Dan Nosowitz<p>The agricultural company J.R. Simplot Company, one of the largest potato producers in the world, struck a deal with the developers of …
GeneticsWe can change human DNA. We're just not sure which bits
It points to a huge problem with genetic editing: it is easy to cut out one gene, but very difficult to be 100 per cent sure other genes weren’t …
GeneticsResearchers say CRISPR edits to a human embryo worked. But critics still doubt it
When researchers announced last year that they had edited human embryos to repair a damaged gene that can lead to heart failure, critics called the …
GeneticsLarge deletions induced by Cas9 cleavage
Brief Communications Arising | Published: 08 August 2018<p><i>Nature</i><b>volume 560</b>, pagesE8–E9 (2018) | Download Citation<p>ARISING FROM H. Ma et al. <i>Nature</i> <b>548</b>, …
Google ScholarUS scientist who edited human embryos with CRISPR responds to critics - MIT Technology Review
Facing criticism from fellow scientists, the researcher behind the world’s largest effort to edit human embryos with CRISPR is vowing to continue his …
GeneticsDid CRISPR really fix a genetic mutation in these human embryos?
NEWS<p>08 August 2018<p>Researchers provide more evidence for their landmark claim that gene editing rid embryos of a disease mutation — but scientists are …
GeneticsCRISPR Therapeutics misses by $0.19, misses on revenue
CRISPR Therapeutics (NASDAQ:CRSP): Q2 EPS of -$0.82 misses by $0.19.<p>Revenue of $1.09M (-69.6% Y/Y) misses by $0.74M.<p>Shares -1.21% AH.<p>Press Release<p>Now …
BusinessCRISPR/Cas in Agrisciences, 2018 Market Research Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--<p>The "CRISPR/Cas in Agrisciences" report has been added to <b>ResearchAndMarkets.com's</b> offering.<p>Over the last few decades, Gene …
GeneticsAllergan to Develop Editas CRISPR Therapy EDIT-101 for LCA10
Allergan plans to develop and commercialize Editas Medicine’s CRISPR genome editing treatment candidate EDIT-101 globally for Leber Congenital …
Chemical EngineeringCRISPR licensing deal could lead to better traits in food, reduce waste
J.R. Simplot is borrowing the technology from DowDuPont, Harvard and MIT, but it will likely be several years before new products reach the …
Agriculture